Marker Therapeutics Announces that Data from Investigator-Sponsored Phase 1 Study With its MultiTAA-Specific T Cells to be Presented at the 2021 American Society of Hematology Annual Meeting

Author's Avatar
Nov 18, 2021

Researchers from Baylor College of Medicine to review results from STELLA study in oral presentation

PR Newswire